COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers

被引:20
|
作者
Katz, J. M. [1 ]
Libman, R. B. [1 ]
Wang, J. J. [3 ]
Filippi, C. G. [2 ]
Sanelli, P. [2 ]
Zlochower, A. [2 ]
Gribko, M. [1 ]
Pacia, S., V [1 ]
Kuzniecky, R., I [1 ]
Najjar, S. [1 ]
Azhar, S. [1 ]
机构
[1] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Neurol, Hempstead, NY 11549 USA
[2] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Radiol, Hempstead, NY 11549 USA
[3] Feinstein Inst Med Res Northwell Hlth, Manhasset, NY USA
关键词
D O I
10.3174/ajnr.A6920
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Coronavirus disease 2019 (COVID-19) appears to be an independent risk factor for stroke. We hypothesize that patients who develop stroke while hospitalized for severe COVID-19 will have higher inflammatory markers and distinct stroke imaging patterns compared with patients positive for COVID-19 with out-of-hospital stroke onset and milder or no COVID-19 symptoms. MATERIALS AND METHODS: This is a retrospective case series of patients positive for COVID-19 on polymerase chain reaction testing with imaging-confirmed stroke treated within a large health care network in New York City and Long Island between March 14 and April 26, 2020. Clinical and laboratory data collected retrospectively included complete blood counts and creatinine, alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer levels. All CT and MR imaging studies were independently reviewed by 2 neuroradiologists who recorded stroke subtype and patterns of infarction and intracranial hemorrhage. RESULTS: Compared with patients with COVID-19 with outside-of-hospital stroke onset and milder or no COVID-19 symptoms (n?=?45, 52.3%), patients with stroke already hospitalized for severe COVID-19 (n?=?41, 47.7%) had significantly more frequent infarctions (95.1% versus 73.3%, P?=?.006), with multivascular distributions (56.4% versus 33.3%, P?=?.022) and associated hemorrhage (31.7% versus 4.4%, P?=?.001). Patients with stroke admitted with more severe COVID-19 had significantly higher C-reactive protein and ferritin levels, elevated D-dimer levels, and more frequent lymphopenia and renal and hepatic injury (all, P?<?.003). CONCLUSIONS: Patients with stroke hospitalized with severe COVID-19 are characterized by higher inflammatory, coagulopathy, and tissue-damage biomarkers, supporting proposed pathogenic mechanisms of hyperinflammation activating a prothrombotic state. Cautious balancing of thrombosis and the risk of hemorrhagic transformation is warranted when considering anticoagulation.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 50 条
  • [1] Degree of COVID-19 severity and mortality in stroke: correlation of clinical and laboratory parameters
    Gofir, Abdul
    Satriotomo, Irawan
    Syamsah, Yossy Catarina Budi Nur
    Rochmah, Mawaddah Ar
    Setyawan, Tommy Rachmat
    Mianoki, Adika
    Silalahi, Raymond Aris Nimrod Alvonsius
    Nugroho, Dhite Bayu
    BMC NEUROSCIENCE, 2024, 25 (01)
  • [2] Degree of COVID-19 severity and mortality in stroke: correlation of clinical and laboratory parameters
    Abdul Gofir
    Irawan Satriotomo
    Yossy Catarina Budi Nur Syamsah
    Mawaddah Ar Rochmah
    Tommy Rachmat Setyawan
    Adika Mianoki
    Raymond Aris Nimrod Alvonsius Silalahi
    Dhite Bayu Nugroho
    BMC Neuroscience, 25
  • [3] Chosen laboratory markers as a determinant of COVID-19 severity
    Navolokin, Ihor
    Tuboltseva, Oleksandra
    Navolokina, Alla
    CARDIOLOGY JOURNAL, 2022, 29 (06) : 1049 - 1050
  • [4] Coagulation Markers And Stroke Severity In Covid-19 Associated Acute Ischemic Stroke
    Ludder, Shaan
    Meyer, Dawn M.
    Rapp, Karen
    Mcquaid, Theresa
    Rico, Jessica
    Gupta, Animesh
    Hemmen, Thomas M.
    STROKE, 2022, 53
  • [5] The Value of Common Laboratory Markers in Predicting the Severity of COVID-19 Patients
    Chen, Lian
    Jiang, Yu-Huan
    Li, Mei-Yong
    Huang, Bo
    Yuan, Lei
    Wan, Jin-Hua
    Qin, Ting-Yu
    Zeng, Ting-Ting
    Chen, Qing-Gen
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 5037 - 5047
  • [6] Correlation of CT severity grade with laboratory findings in COVID-19 patients
    Dhok, Avinash
    Mitra, Kajal
    Daptardar, Rujuta
    Jakhotia, Yash
    MEDICAL SCIENCE, 2022, 26 (124)
  • [7] Clinical Laboratory Markers in COVID-19
    Iqbal, Mohammad Zahidul
    Zohra, Benazeer
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2021, 27 (04): : 576 - 585
  • [8] Predictors of the severity of the course of COVID-19: demographic factors, clinical signs and laboratory markers
    Bartoszewicz, Klaudia
    Bartoszewicz, Mateusz
    Stroz, Samuel
    Stasiak-Barmuta, Anna
    Kosiorek, Piotr
    JOURNAL OF MEDICAL MICROBIOLOGY, 2024, 73 (10)
  • [9] Cycle Threshold Values Predict COVID-19 Severity and Mortality but Are not Correlated with Laboratory Markers
    Esmaeili, Behnaz
    Khoshnevis, Hoda
    Alirezaee, Atefe
    Shakoori, Abbas
    Pourpak, Zahra
    Chegini, Hamid
    Ahmadinejad, Zahra
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2023, 22 (05) : 468 - 481
  • [10] Laboratory markers as predictor factor of clinical and radiological severity in hospitalized patient with covid-19
    Fehri, S. Majdoub
    Ketata, I
    Sellami, R.
    Medi, W.
    Kwass, H.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60